• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑瘤 microRNA-152 通过靶向 CDK5R1 抑制尤文肉瘤细胞的增殖。

Tumor-suppressive microRNA-152 inhibits the proliferation of Ewing's sarcoma cells by targeting CDK5R1.

机构信息

Department of Orthopaedic Surgery, Faculty of Medicine, Oita University, Oita, 879-5593, Japan.

出版信息

Sci Rep. 2023 Oct 29;13(1):18546. doi: 10.1038/s41598-023-45833-6.

DOI:10.1038/s41598-023-45833-6
PMID:37899376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10613623/
Abstract

We elucidated the mechanism through which the reduced expression of miR-152 leads to the overexpression of its target cyclin-dependent kinase-5 activator 1 (CDK5R1) in Ewing's sarcoma (ES) cells and the role of this mechanism in the proliferation of ES cells. To explore possible oncogenic factors in ES, we conducted microarray-based investigation and profiled the changes in miRNA expression and their effects on downstream mRNAs in five ES cell lines and human mesenchymal stem cells (hMSCs). miR-152 was significantly downregulated, while cyclin-dependent kinase-5 activator 1 (CDK5R1) expression was significantly upregulated in all tested ES cells as compared to hMSCs. The overexpression of CDK5R1 led to the activation of CDK5, enabling the phosphorylation of retinoblastoma protein and persistent overexpression of CCNE. Moreover, miR-152 suppressed cell proliferation via cell cycle retardation, and its upregulation reduced tumor size and CCNE expression in tumor tissues. The overexpression of cyclin E (CCNE) has been detected in ES cells, but the detailed mechanisms have not been previously elucidated. These findings identify the miR152-CDK5R1 signaling axis as a critical mechanism for tumorigenesis that may serve as a new therapeutic target in Ewing's sarcoma. We believe that our results will aid in the development of effective treatment strategies for patients with ES.

摘要

我们阐明了机制,即 miR-152 的表达减少导致其靶标细胞周期蛋白依赖性激酶 5 激活物 1(CDK5R1)在尤文肉瘤(ES)细胞中的过度表达,以及该机制在 ES 细胞增殖中的作用。为了探索 ES 中可能的致癌因素,我们进行了基于微阵列的调查,并对五种 ES 细胞系和人间充质干细胞(hMSC)中的 miRNA 表达变化及其对下游 mRNA 的影响进行了分析。与 hMSC 相比,miR-152 在所有测试的 ES 细胞中均显著下调,而细胞周期蛋白依赖性激酶 5 激活物 1(CDK5R1)的表达则显著上调。CDK5R1 的过表达导致 CDK5 的激活,使视网膜母细胞瘤蛋白磷酸化和 CCNE 的持续过表达。此外,miR-152 通过细胞周期阻滞抑制细胞增殖,上调 miR-152 可减少肿瘤组织中的肿瘤大小和 CCNE 表达。CCNE 的过表达已在 ES 细胞中检测到,但详细机制尚未阐明。这些发现确定了 miR152-CDK5R1 信号轴作为肿瘤发生的关键机制,可能成为尤文肉瘤的新治疗靶点。我们相信,我们的研究结果将有助于为 ES 患者开发有效的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dce/10613623/e652f63731dc/41598_2023_45833_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dce/10613623/cd4289b27f74/41598_2023_45833_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dce/10613623/4d45d9c9e237/41598_2023_45833_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dce/10613623/2c2f24a23cea/41598_2023_45833_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dce/10613623/f66a6e2d80de/41598_2023_45833_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dce/10613623/e652f63731dc/41598_2023_45833_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dce/10613623/cd4289b27f74/41598_2023_45833_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dce/10613623/4d45d9c9e237/41598_2023_45833_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dce/10613623/2c2f24a23cea/41598_2023_45833_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dce/10613623/f66a6e2d80de/41598_2023_45833_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1dce/10613623/e652f63731dc/41598_2023_45833_Fig5_HTML.jpg

相似文献

1
Tumor-suppressive microRNA-152 inhibits the proliferation of Ewing's sarcoma cells by targeting CDK5R1.抑瘤 microRNA-152 通过靶向 CDK5R1 抑制尤文肉瘤细胞的增殖。
Sci Rep. 2023 Oct 29;13(1):18546. doi: 10.1038/s41598-023-45833-6.
2
MicroRNA-301a promotes cell proliferation via PTEN targeting in Ewing's sarcoma cells.微小RNA-301a通过靶向PTEN促进尤因肉瘤细胞的增殖。
Int J Oncol. 2016 Apr;48(4):1531-40. doi: 10.3892/ijo.2016.3379. Epub 2016 Feb 5.
3
c-Myc Represses Tumor-Suppressive microRNAs, let-7a, miR-16 and miR-29b, and Induces Cyclin D2-Mediated Cell Proliferation in Ewing's Sarcoma Cell Line.c-Myc抑制肿瘤抑制性微小RNA(let-7a、miR-16和miR-29b),并在尤因肉瘤细胞系中诱导细胞周期蛋白D2介导的细胞增殖。
PLoS One. 2015 Sep 22;10(9):e0138560. doi: 10.1371/journal.pone.0138560. eCollection 2015.
4
MiR-125b inhibits cell biological progression of Ewing's sarcoma by suppressing the PI3K/Akt signalling pathway.miR-125b 通过抑制 PI3K/Akt 信号通路抑制尤文肉瘤的细胞生物学进展。
Cell Prolif. 2014 Apr;47(2):152-60. doi: 10.1111/cpr.12093. Epub 2014 Feb 12.
5
MicroRNA-20b promotes cell proliferation via targeting of TGF-β receptor II and upregulates MYC expression in Ewing's sarcoma cells.微小 RNA-20b 通过靶向转化生长因子-β 受体 II 促进尤文肉瘤细胞增殖,并上调 MYC 表达。
Int J Oncol. 2017 Dec;51(6):1842-1850. doi: 10.3892/ijo.2017.4155. Epub 2017 Oct 12.
6
Tumor suppressive microRNA-138 inhibits metastatic potential via the targeting of focal adhesion kinase in Ewing's sarcoma cells.抑瘤微小 RNA-138 通过靶向黏着斑激酶抑制尤文肉瘤细胞的转移潜能。
Int J Oncol. 2016 Mar;48(3):1135-44. doi: 10.3892/ijo.2016.3317. Epub 2016 Jan 5.
7
Ewing's Sarcoma: An Analysis of miRNA Expression Profiles and Target Genes in Paraffin-Embedded Primary Tumor Tissue.尤因肉瘤:石蜡包埋的原发肿瘤组织中miRNA表达谱及靶基因分析
Int J Mol Sci. 2016 Apr 30;17(5):656. doi: 10.3390/ijms17050656.
8
MicroRNA-181c prevents apoptosis by targeting of FAS receptor in Ewing's sarcoma cells.微小RNA-181c通过靶向尤因肉瘤细胞中的FAS受体来防止细胞凋亡。
Cancer Cell Int. 2018 Mar 12;18:37. doi: 10.1186/s12935-018-0536-9. eCollection 2018.
9
Overexpression of miR‑199b‑5p inhibits Ewing's sarcoma cell lines by targeting CCNL1.miR-199b-5p的过表达通过靶向CCNL1抑制尤因肉瘤细胞系。
Mol Med Rep. 2015 Sep;12(3):3359-3364. doi: 10.3892/mmr.2015.3888. Epub 2015 Jun 3.
10
Targeting Lyn inhibits tumor growth and metastasis in Ewing's sarcoma.靶向Lyn可抑制尤因肉瘤的肿瘤生长和转移。
Mol Cancer Ther. 2008 Jul;7(7):1807-16. doi: 10.1158/1535-7163.MCT-08-0058.

本文引用的文献

1
Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0.报告动物研究:ARRIVE 指南 2.0 的解释和说明。
PLoS Biol. 2020 Jul 14;18(7):e3000411. doi: 10.1371/journal.pbio.3000411. eCollection 2020 Jul.
2
miR-152-5p suppresses glioma progression and tumorigenesis and potentiates temozolomide sensitivity by targeting FBXL7.miR-152-5p 通过靶向 FBXL7 抑制神经胶质瘤的进展和肿瘤发生并增强替莫唑胺敏感性。
J Cell Mol Med. 2020 Apr;24(8):4569-4579. doi: 10.1111/jcmm.15114. Epub 2020 Mar 9.
3
ARID1A prevents squamous cell carcinoma initiation and chemoresistance by antagonizing pRb/E2F1/c-Myc-mediated cancer stemness.
ARID1A 通过拮抗 pRb/E2F1/c-Myc 介导的癌症干性来预防鳞状细胞癌的起始和化疗耐药性。
Cell Death Differ. 2020 Jun;27(6):1981-1997. doi: 10.1038/s41418-019-0475-6. Epub 2019 Dec 12.
4
CDK5: A Unique CDK and Its Multiple Roles in the Nervous System.CDK5:一种独特的 CDK 及其在神经系统中的多种作用。
J Alzheimers Dis. 2019;68(3):843-855. doi: 10.3233/JAD-180792.
5
Tissue-type plasminogen activator regulates p35-mediated Cdk5 activation in the postsynaptic terminal.组织型纤溶酶原激活物调节突触后末端 p35 介导的 Cdk5 的激活。
J Cell Sci. 2019 Feb 28;132(5):jcs224196. doi: 10.1242/jcs.224196.
6
Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor-Positive Early Breast Cancer: PALLET Trial.随机 II 期研究评估帕博西尼联合来曲唑作为雌激素受体阳性早期乳腺癌新辅助治疗:PALLET 试验。
J Clin Oncol. 2019 Jan 20;37(3):178-189. doi: 10.1200/JCO.18.01624. Epub 2018 Dec 6.
7
Restoration of miR-152 expression suppresses cell proliferation, survival, and migration through inhibition of AKT-ERK pathway in colorectal cancer.恢复 miR-152 的表达通过抑制结直肠癌细胞中的 AKT-ERK 通路抑制细胞增殖、存活和迁移。
J Cell Physiol. 2018 Jan;234(1):769-776. doi: 10.1002/jcp.26891. Epub 2018 Aug 4.
8
Interaction between human osteosarcoma and mesenchymal stem cells via an interleukin-8 signaling loop in the tumor microenvironment.肿瘤微环境中白细胞介素-8 信号通路介导骨肉瘤与间充质干细胞的相互作用。
Cell Commun Signal. 2018 Apr 6;16(1):13. doi: 10.1186/s12964-018-0225-2.
9
MicroRNA-181c prevents apoptosis by targeting of FAS receptor in Ewing's sarcoma cells.微小RNA-181c通过靶向尤因肉瘤细胞中的FAS受体来防止细胞凋亡。
Cancer Cell Int. 2018 Mar 12;18:37. doi: 10.1186/s12935-018-0536-9. eCollection 2018.
10
Biological functions of CDK5 and potential CDK5 targeted clinical treatments.CDK5的生物学功能及潜在的以CDK5为靶点的临床治疗方法。
Oncotarget. 2017 Mar 7;8(10):17373-17382. doi: 10.18632/oncotarget.14538.